Alan Scott Enterprises Ltd
Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes
- Market Cap ₹ 166 Cr.
- Current Price ₹ 304
- High / Low ₹ 345 / 92.0
- Stock P/E 159
- Book Value ₹ 13.3
- Dividend Yield 0.00 %
- ROCE -13.3 %
- ROE -17.1 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 22.8 times its book value
- Company has a low return on equity of -23.1% over last 3 years.
- Earnings include an other income of Rs.1.97 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.13 | 0.27 | 0.18 | 0.11 | 0.23 | 0.12 | 0.05 | 0.02 | 1.11 | 0.37 | 0.18 | 0.00 | 0.40 | |
| 0.13 | 0.27 | 0.33 | 0.25 | 0.20 | 0.11 | 0.12 | 0.11 | 1.78 | 1.46 | 1.29 | 1.28 | 1.29 | |
| Operating Profit | 0.00 | 0.00 | -0.15 | -0.14 | 0.03 | 0.01 | -0.07 | -0.09 | -0.67 | -1.09 | -1.11 | -1.28 | -0.89 |
| OPM % | 0.00% | 0.00% | -83.33% | -127.27% | 13.04% | 8.33% | -140.00% | -450.00% | -60.36% | -294.59% | -616.67% | -222.50% | |
| 0.06 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.67 | 0.16 | 0.23 | 1.99 | 1.97 | |
| Interest | 0.00 | 0.01 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.00 |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.08 | 0.06 | 0.04 | 0.04 |
| Profit before tax | 0.05 | 0.02 | -0.15 | -0.15 | 0.01 | 0.01 | -0.07 | 0.00 | -0.02 | -1.03 | -0.96 | 0.66 | 1.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| 0.05 | 0.02 | -0.15 | -0.16 | 0.00 | 0.01 | -0.07 | 0.00 | -0.02 | -1.04 | -0.96 | 0.65 | 1.04 | |
| EPS in Rs | 0.05 | 0.02 | -0.15 | -0.16 | 0.00 | 0.05 | -0.35 | 0.00 | -0.04 | -1.93 | -1.78 | 1.20 | 1.92 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 122% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -42% |
| TTM: | 195% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 96% |
| 3 Years: | 132% |
| 1 Year: | 184% |
| Return on Equity | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -23% |
| 3 Years: | -23% |
| Last Year: | -17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.26 | 3.26 | 3.26 | 3.26 | 0.69 | 0.69 | 0.69 | 1.19 | 1.83 | 1.83 | 3.62 | 3.63 |
| Reserves | -2.63 | -2.61 | -2.77 | -2.93 | -0.35 | -0.34 | -0.41 | 0.35 | 1.28 | 0.25 | 2.86 | 3.57 |
| 0.05 | 0.00 | 0.08 | 0.10 | 0.02 | 0.00 | 0.00 | 0.05 | 0.17 | 0.55 | 1.49 | 2.14 | |
| 0.02 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 | 0.18 | 0.16 | 0.17 | 0.22 | |
| Total Liabilities | 0.70 | 0.66 | 0.58 | 0.45 | 0.36 | 0.35 | 0.29 | 1.59 | 3.46 | 2.79 | 8.14 | 9.56 |
| 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.19 | 0.13 | 0.10 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.30 | 0.29 | 0.44 | 3.82 | 5.24 |
| 0.69 | 0.63 | 0.55 | 0.43 | 0.34 | 0.35 | 0.29 | 1.29 | 2.95 | 2.16 | 4.19 | 4.22 | |
| Total Assets | 0.70 | 0.66 | 0.58 | 0.45 | 0.36 | 0.35 | 0.29 | 1.59 | 3.46 | 2.79 | 8.14 | 9.56 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.30 | 0.03 | -0.12 | -0.07 | 0.07 | 0.06 | -0.05 | 0.18 | -1.97 | -1.75 | -1.36 | -3.01 | |
| 0.11 | -0.02 | -0.01 | 0.00 | 0.00 | 0.02 | 0.00 | -0.21 | -0.61 | 0.96 | -3.16 | 0.60 | |
| -0.04 | -0.05 | 0.07 | 0.03 | -0.08 | -0.02 | 0.00 | 1.29 | 1.77 | 0.36 | 6.28 | 0.71 | |
| Net Cash Flow | -0.23 | -0.04 | -0.06 | -0.04 | -0.01 | 0.05 | -0.05 | 1.26 | -0.81 | -0.43 | 1.77 | -1.70 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 842.31 | 81.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.86 | 446.11 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 69.16 | 438.00 | 268.95 | |||||
| Days Payable | 65.32 | 175.20 | 268.95 | |||||||||
| Cash Conversion Cycle | 842.31 | 81.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.84 | 272.66 | 446.11 | |
| Working Capital Days | 1,291.54 | 689.44 | 811.11 | 962.27 | 491.96 | 821.25 | 1,898.00 | -730.00 | 378.15 | 1,351.49 | 1,176.11 | |
| ROCE % | -1.57% | 4.51% | -24.59% | -28.00% | 7.59% | 2.82% | -22.22% | -9.63% | -26.28% | -34.18% | -17.74% | -13.29% |
Documents
Announcements
-
Update on board meeting
1d - Board meeting rescheduled to Nov 13; approve Sep-30 results; acquire 60% of AQL for INR 3,00,000.
-
Board Meeting Intimation for Intimation Of Meeting Of The Board Pursuant To Regulation 29 Of SEBI (LODR) Regulations, 2015.
31 Oct - Board meeting Nov 6; acquire 60% of Alanscott Qubiverse for INR3,00,000 (30,000 shares at INR10).
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
30 Oct - EOGM Oct 30, 2025: approved preferential share issue; appointed Dr. Rishi M. Bhatnagar; 66.89% turnout.
-
Shareholder Meeting / Postal Ballot-Outcome of EGM
30 Oct - Oct 30, 2025 EOGM approved 500,000 shares at ₹250 each (₹12.5 crore) and director appointment.
-
Subsidiary Update - Product Launch By Alan Scott Omnis AI Private Limited.
24 Oct - Alan Scott subsidiary Omnis AI launched Zynd AI agent orchestration platform, announced 24 Oct 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2006
from bse
-
Financial Year 2005
from bse
Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%
Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3